US states that legalize medical cannabis don’t tend to see a decline in opioid prescriptions for non-cancer pain. That’s the main finding of a new study from researchers at Weill Cornell Medicine.
The FTC say this kind of marketing is “reckless” as the emulated products are appealing to children.
Comments from the public and relevant professionals are welcome and will be accepted until August 25.
The batches were harvested between October 2022 and January 2023 by three separate cultivators.
Cannabis consumers in Nevada have been advised by the state’s cannabis regulator to avoid or “take caution” when consuming the “Dancing Monkey” product.
Given this vast oversupply of cannabis, the study says it is likely that, to offload their products, many licensed medical cannabis businesses are supplying the state’s illicit market.
Brady Green, head grower at UK-based medicinal cannabis firm Dalgety, explains the differences between the country's illicit and legal medical cannabis markets, and why the latter needs to be the first-choice for patients.
As of June 14, no illnesses have been linked to the products.
The cannabis regulator in Colorado has identified ‘many examples’ of adulterated test batches, according to a recent notice.